SOX18 meditates the resistance of Bmi1-expressing cells to cetuximab in HNSCC.
Caihua ZhangZhi ChenNailin GaoGan XiongPeng ChenHui LiDemeng ChenQianting HeLiang PengPublished in: Oral diseases (2023)
Taken together, the findings of our study suggest that Sox18 mediates the resistance of Bmi1-expressing cells to cetuximab in HNSCC via the oxidative phosphorylation pathway.